<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03935581</url>
  </required_header>
  <id_info>
    <org_study_id>ET004</org_study_id>
    <nct_id>NCT03935581</nct_id>
  </id_info>
  <brief_title>Safety and Feasibility of ExAblate Neuro System to Perform Auto-Focusing Echo Imaging in Patients With Essential Tremor</brief_title>
  <acronym>ET004</acronym>
  <official_title>Assessment of Safety and Feasibility of ExAblate Neuro System to Perform Auto-Focusing Echo Imaging in Patients With Idiopathic Essential Tremor With Medication Refractory Tremor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InSightec</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InSightec</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the safety and feasibility of Auto Focusing (AF)&#xD;
      echo imaging using the ExAblate Neuro system&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This clinical investigation is a feasibility study designed to evaluate the safety and&#xD;
      feasibility of the ExAblate Neuro system to perform AF echo imaging in patients diagnosed&#xD;
      with idiopathic Essential Tremor. during the standard care procedure for ET, patients will be&#xD;
      injected with Definity microbubbles which will enable the ExAblate Neuro system to perform&#xD;
      the AF imaging.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 25, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Device and Procedure related Adverse Events</measure>
    <time_frame>Treatment through 1 month</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Tremor, Essential</condition>
  <condition>Neurologic Manifestations</condition>
  <condition>Tremor</condition>
  <arm_group>
    <arm_group_label>ExAblate 4000 System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ExAblate Neuro system to perform AF echo imaging in treatment of Essential Tremor</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ExAblate</intervention_name>
    <description>Auto Focusing (AF) echo imaging</description>
    <arm_group_label>ExAblate 4000 System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or Female age 22 years or older&#xD;
&#xD;
          2. Able and willing to give consent and able to attend all study visits&#xD;
&#xD;
          3. A confirmed diagnosis of Essential Tremor resistant to medication therapy&#xD;
&#xD;
          4. Able to fit into MRI unit&#xD;
&#xD;
          5. Able to tolerate the procedure with or without some form of sedation&#xD;
&#xD;
          6. Able to communicate sensations during the ExAblate MRgFUS procedure&#xD;
&#xD;
          7. Able to activate Stop Sonication button during the ExAblate MRgFUS procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Presence of unknown or MRI unsafe devices anywhere in the body.&#xD;
&#xD;
          2. Patients with known intolerance or allergies to the MRI contrast agents&#xD;
&#xD;
          3. Women who are pregnant&#xD;
&#xD;
          4. Patients with advanced kidney disease or on dialysis&#xD;
&#xD;
          5. Significant cardiac disease or unstable hemodynamic status&#xD;
&#xD;
          6. Patients exhibiting any behavior(s) consistent with ethanol or substance abuse&#xD;
&#xD;
          7. History of a bleeding disorder&#xD;
&#xD;
          8. Patients receiving anticoagulant or drugs known to increase risk of hemorrhage&#xD;
&#xD;
          9. Patients with cerebrovascular disease&#xD;
&#xD;
         10. Patients with brain tumors&#xD;
&#xD;
         11. Individuals who are not able or unwilling to tolerate the required prolonged&#xD;
             stationary position during treatment (approximately 2-3 hours)&#xD;
&#xD;
         12. Patients who are currently participating in another clinical investigation&#xD;
&#xD;
         13. Patients unable to communicate with the investigator and staff&#xD;
&#xD;
         14. Patients who have cardiac shunts&#xD;
&#xD;
         15. Patients with relative contraindications to Definity ultrasound contrast agent&#xD;
             including subjects with a family or personal history of arrhythmia's&#xD;
&#xD;
         16. Patients with chronic pulmonary disorders&#xD;
&#xD;
         17. Patients with a history of drug allergies, uncontrolled asthma or hay fever&#xD;
&#xD;
         18. Patients who have had deep brain stimulation or a prior neuroablative procedure&#xD;
&#xD;
         19. Women who are pregnant or nursing&#xD;
&#xD;
         20. Patients who have been administered botulinum toxins into the arm, neck, or face for 5&#xD;
             months prior to enrollment in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nir Lipsman</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Science Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sunnybrook</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yonsei University Health System, Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Seodaemun-gu</state>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 18, 2019</study_first_submitted>
  <study_first_submitted_qc>May 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2019</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MRgFUS</keyword>
  <keyword>ExAblate</keyword>
  <keyword>Essential Tremor</keyword>
  <keyword>Auto-Focusing Echo Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tremor</mesh_term>
    <mesh_term>Essential Tremor</mesh_term>
    <mesh_term>Neurologic Manifestations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

